Author

M. Steiner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1 Organism:rat· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Ben-Shmuel· 1 shared A. Beth-Din· 1 shared A. Nyska· 1 shared A. Rosner· 1 shared A. Sharma· 1 shared A. Sittner· 1 shared B. Politi· 1 shared D. Neureiter· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Ben-Shmuel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Hedgehog-Hippo pathway interactions promote T cell exclusion from the tumor microenvironment in basal cell carcinoma

G. Stockmaier, S. Varkhande, P. W. Krenn, H.-h. Dang, A. Sharma, D. P. Elmer, M. Steiner, N. Zaborsky, D. Neureiter, R. Greil, J. Horejs-Hoeck, N. Fortelny, I. K. Gratz, F. Aberger

This study shows that HH/GLI and Hippo/YAP pathway interactions suppress T cell chemotaxis and promote immunosuppression in BCC by downregulating chemokine signaling.

bioRxiv · Jul 7, 2024 · PreprintCancer Biology

Nonclinical Safety and Immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

N. Madar-Balakirski, A. Rosner, S. Melamed, B. Politi, M. Steiner, H. Tamir, Y. Yahalom Ronen, E. Bar-David, A. Ben-Shmuel, A. Sittner, I. Glinert, S. Weiss, E. Bar-Haim, H. Cohen, U. Elia, , H. Marcus

This study evaluates the safety, immunogenicity, and efficacy of an rVSV-ΔG-SARS-CoV-2-S vaccine in multiple animal species, finding no adverse effects and a robust immune response.

bioRxiv · Jul 6, 2021Pharmacology & Toxicology